Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$322,236,881
+$3,069,130 QoQ
Shares Held
1,268,799
-2.8% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#144
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chevy Chase Trust Holdings, LLC holds $1,644,743,184 across 12 Drug Manufacturers - General names. JNJ ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
389,384 | $467,038,889 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,268,799 | $322,236,881 | |
| 3 | ABBV |
AbbVie Inc.
|
883,270 | $222,266,062 | |
| 4 | NVS |
Novartis AG
|
1,033,709 | $162,002,874 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,222,498 | $157,090,992 | |
| 6 | AMGN |
Amgen Inc
|
266,650 | $96,559,297 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
605,105 | $76,448,965 | |
| 8 | PFE |
Pfizer Inc
|
2,789,125 | $67,162,129 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,236,881 | 1,268,799 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $319,167,751 | 1,305,710 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $280,196,019 | 1,353,931 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $252,220,150 | 1,360,264 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $214,062,017 | 1,401,388 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $230,906,494 | 1,392,345 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $202,337,986 | 1,399,101 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $239,340,093 | 1,476,861 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $219,502,941 | 1,501,799 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $281,051,268 | 1,776,669 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $277,021,491 | 1,767,395 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $290,415,499 | 1,864,626 | Shares | Defined | 2023-10-23 | |
| 2023-06-30 | $331,173,243 | 2,000,805 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $324,315,955 | 2,092,361 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $339,387,222 | 1,921,241 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $334,325,224 | 2,046,555 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $350,151,077 | 1,972,571 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $322,221,862 | 1,818,100 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $311,248,178 | 1,819,420 | Shares | Defined | 2022-01-31 | |
| 2021-09-30 | $300,871,108 | 1,862,979 | Shares | Defined | 2021-10-20 | |
| 2021-06-30 | $322,539,668 | 1,957,871 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $335,931,892 | 2,044,003 | Shares | Defined | 2021-04-22 | |
| 2020-12-31 | $341,341,954 | 2,168,903 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $333,349,316 | 2,239,047 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $337,734,897 | 2,401,585 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $330,176,554 | 2,517,933 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||